Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenstr öm Macroglobulinemia
Conditions: Waldenstrom's Disease; Waldenstrom Macroglobulinemia Interventions: Biological: bone marrow sample; Biological: blood sample Sponsors: Centre Hospitalier Universitaire, Amiens; Centre Henri Becquerel; University Hospital, Caen; University Hospital, Lille; Centre Hospitalier de Lens Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials